Simulations Plus, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
SLP Nasdaq 8081 www.simulations-plus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Simulations Plus, Inc.

Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results - Jul 9th, 2026 2:05 pm
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Jun 26th, 2026 12:30 am
Sylvania Platinum (AIM:SLP) Stock Sees Modest Fair Value Lift As Analysts Weigh Cash Generation - Jun 22nd, 2026 10:30 pm
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets - Jun 19th, 2026 7:09 pm
Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls - Jun 17th, 2026 7:47 am
Altaris to acquire Simulations Plus in $375m all-cash deal - Jun 17th, 2026 3:56 am
Why Shares in Simulation Plus Soared Today - Jun 16th, 2026 11:24 am
Dividend Investors: Don't Be Too Quick To Buy SLP Resources Berhad (KLSE:SLP) For Its Upcoming Dividend - Jun 11th, 2026 5:50 pm
How The Investment Story Is Evolving For Sylvania Platinum (AIM:SLP) - Jun 7th, 2026 9:09 pm
Is It Too Late To Consider Buying Simulations Plus, Inc. (NASDAQ:SLP)? - May 29th, 2026 4:11 am
NVIDIA (NVDA): The Best Quality Stock to Buy and Hold for the Next 5 Years - May 9th, 2026 4:14 am
PTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares Jump - May 7th, 2026 8:49 am
Do Options Traders Know Something About Simulations Plus Stock We Don't? - May 4th, 2026 10:53 am
Biosimulation Market Research and Global Forecast Report 2026-2036: Expansion Driven by Precision Medicine, AI-Powered In-Silico Drug Development and Rising Demand for Cost-Efficient Clinical Trials - Apr 22nd, 2026 8:33 am